Get started
Author

Philip Ströbel

Neoadjuvant Imatinib in Advanced Primary or Locally Recurrent Dermatofibrosarcoma Protuberans: A Multicenter Phase II DeCOG Trial with Long-term Follow-up
2013 · Selma Ugurel, Thomas Mentzel, et al. · Clinical Cancer Research · 148
Factors Predicting Long-Term Survival Following Pancreatic Resection for Ductal Adenocarcinoma of the Pancreas: 40 Years of Experience
2013 · Niloufar Dusch, Christel Weiss, et al. · Journal of Gastrointestinal Surgery · 68
Gene Expression in Solitary Fibrous Tumors (SFTs) Correlates with Anatomic Localization and NAB2-STAT6 Gene Fusion Variants
2021 · Matthias Bieg, Evgeny A. Moskalev, et al. · American Journal Of Pathology · 54
PDF
Pathology of thymic tumors
2005 · Robert P. Hasserjian, Philip Ströbel, et al. · Seminars in Thoracic and Cardiovascular Surgery · 44
Inactivating Mutations ofRB1andTP53Correlate With Sarcomatous Histomorphology and Metastasis/Recurrence in Gastrointestinal Stromal Tumors
2016 · Larissa Merten, Abbas Agaimy, et al. · American Journal of Clinical Pathology · 31
Lipomatous Solitary Fibrous Tumors Harbor Rare NAB2-STAT6 Fusion Variants and Show Up-Regulation of the Gene PPARG, Encoding for a Regulator of Adipocyte Differentiation
2021 · Florian Haller, Lea D. Schlieben, et al. · American Journal Of Pathology · 13
PDF
Abstract 5565: Multiomic characterization of colorectal cancer using MICS technology reveals interaction of antigen presenting cancer associated fibroblasts and T cells
2024 · Emily Neil, Rebecca C. Hennessey, et al. · Cancer Research · 1
Data from Neoadjuvant Imatinib in Advanced Primary or Locally Recurrent Dermatofibrosarcoma Protuberans: A Multicenter Phase II DeCOG Trial with Long-term Follow-up
2023 · Selma Ugurel, Thomas Mentzel, et al.
Supplementary Methods, Tables 1 - 2 from Neoadjuvant Imatinib in Advanced Primary or Locally Recurrent Dermatofibrosarcoma Protuberans: A Multicenter Phase II DeCOG Trial with Long-term Follow-up
2023 · Selma Ugurel, Thomas Mentzel, et al.
2230 Validation of the New Biomarker Micro-rna-221 to Predict Cancer Related Death in High-risk Prostate Carcinoma - Results of a Metaanalysis
2012 · Martin Spahn, Claus Jürgen, et al. · The Journal of Urology
1122 Development of a Novel Preoperative Nomogram Including the Biomarker Micro-rna 221 - Predicting Cancer Specific Mortality in High Risk Prostate Cancer
2012 · Martin Spahn, Firas Abdolah, et al. · The Journal of Urology
1290 Development of New Mouse Models for Insignificant and Lethal Prostate Cancer
2011 · Martin Spahn, Cora Reiß, et al. · The Journal of Urology
1630 Micro-rna-221 Is a Strong and Independent Predictor of Clinical Progression and Css in High-risk Prostate Cancer
2011 · Martin Spahn, Steven Joniau, et al. · The Journal of Urology
544 Prostate Specific Deletion of the Mismatch Repair (mmr) Gene Mlh1 in Mice Cause Neoplastic Alterations of the Prostate
2010 · Burkhard Kneitz, Cora Reiß, et al. · The Journal of Urology
Pdkl-11 Genetic Basis and Molecular Features of the New Who Classification of Thymomas
2004 · Hans Konrad Müller‐Hermelink, G. Chen, et al. · 日本外科学会雑誌
Works count: 15
Citation count: 359
H-index: 6
I10-index: 6
Year
Topic
Type